R eplication stress is a primary threat to genome stability and has been implicated in tumorigenesis [1] [2] [3] . Notably, most recurrent deletions cataloged in cancer cells colocalize with chromosomal regions particularly prone to breakage following mild replication stress known as common fragile sites 4, 5 . CFSs are cell-type specific [5] [6] [7] and are often associated with very large genes in human, mouse or chicken cells 4, 5, [8] [9] [10] [11] [12] . CFSs replicate late in S phase 4, 13 , and it is largely agreed that they remain incompletely replicated until mitosis in case of replication stress 4 . Incompletely replicated regions are then processed by specific endonucleases promoting mitotic DNA synthesis and sister chromatid separation, eventually at the cost of chromosomal rearrangements [14] [15] [16] [17] [18] [19] . Different mechanisms have been suggested to explain the tissue-specific delay in replication completion at CFSs. One postulates that transcription-dependent replication barriers, namely R-loops 9, 10, 12, 20 , lead to fork stalling and collapse. The other mechanism relies on recurrent observations that the core of large genes is poor in initiation events 6, 7, 21 . Slowing of long-traveling forks emanating from flanking regions would therefore result in a specific delay of the replication of the core. In this model, the tissue specificity of CFS instability would be a result of the epigenetic setting of the replication program 22 . This does not preclude a role for transcription in CFS instability, as transcription may influence replication dynamics. In addition, AT-rich sequences have been proposed to contribute to fragility 20, [23] [24] [25] [26] . Notably, long poly(dA:dT) tracts are preferential sites of replication fork stalling 26 and promote R-loop formation 27 . Although the tissue specificity of CFSs strongly argues against an exclusive role of cis-acting DNA features in CFS instability, AT-rich tracts may thus increase replication failure at CFSs.
Here we directly addressed the impact of transcription on the replication program and fragility of very large genes. For this purpose, we manipulated the transcription of such genes in chicken lymphoblastoid DT40 cells, where targeted DNA modification by homologous recombination is very efficient 28 , and in human colon carcinoma HCT116 cells using the CRISPR-Cas9 technique. We found that these manipulations quantitatively affected all three parameters of the replication program, namely initiation events, fork progression, and replication timing, as well as the fragility of large genes.
Results
Activation of DMD transcription induces its fragility in DT40 cells. We first focused on DMD, the largest annotated avian gene (Fig. 1) . DMD encodes dystrophin, a protein that has a key role in muscle cells; mutations in human DMD cause Duchenne muscular dystrophy, Becker muscular dystrophy, or cardiomyopathy 29 . The human ortholog of DMD is associated with FRAXC CFS 8 . DMD extends over 996 kb in the chicken genome, is replicated late, and is neither transcribed nor fragile in DT40 cells 12 . We activated its transcription by inserting a tetracycline-inducible promoter (Tet promoter) on both alleles ( Supplementary Fig. 1) . A low level of DMD transcription from the Tet promoter was detected in DMD Tet/Tet cells grown without tetracycline (Fig. 1a) . Notably, fluorescent in situ hybridization (FISH) analysis of breaks induced in DMD by the DNA polymerase inhibitor aphidicolin revealed that the gene became fragile in these cells (Fig. 1b, Supplementary  Fig. 2a , and Supplementary Table 1 ). Addition of tetracycline increased both DMD mRNA levels ( Fig. 1a) and DMD instability (Fig. 1b, Supplementary Fig. 2a , and Supplementary Table 1) . On the other hand, aphidicolin-induced breaks at the 679.5-kb-long PARK2 gene, a major CFS of the DT40 genome 12 , were not affected by DMD transcriptional status (Fig. 1b, Supplementary Fig. 2b Ter. (49) Coverage ( Table 1) . Our results therefore strongly support a major role of transcription in CFS instability.
Activation of DMD transcription modifies its replication initiation pattern, but not its replication timing, in DT40 cells. We then examined the replication program of DMD in wild-type (WT) cells and in DMD Tet/Tet cells grown in the presence of tetracycline. We used DNA combing and designed a specific set of FISH probes to visualize neo-synthesized DNA along single molecules spanning DMD, which permitted us to measure the speed of individual forks and to map initiation and termination events along the locus ( Supplementary Figs. 3 and 4a ). Initiation and termination events appeared randomly distributed along DMD in WT cells (Fig. 1c) . In marked contrast, initiation events accumulated in the Tet promoter region when DMD was transcribed, and a large region depleted of initiation events extended over the 5′ part of the gene (Fig. 1d) . Initiation events also clustered in a second, ~300-kb-large zone located in the 3′ half of active DMD. As expected, modifications of the initiation profile resulted in a redistribution of termination events. Active DMD remained late replicating (S4 fraction) (Fig. 1e,f) , confirming that transcription per se is not sufficient to impose early replication 30, 31 . Thus, in line with recent analyses [32] [33] [34] [35] , our results support a model in which transcriptional activity modulates origin distribution, which may account for the frequent localization of origins near transcription start sites 21, 36, 37 . In addition, activation of DMD transcription specifically increased fork speed along the DMD locus (Fig. 1g) , suggesting that transcription regulates chromatin permissiveness to fork progression. Consistently, chromatin factors such as the histone chaperone FACT (facilitates chromatin transcription), which participates in the disassembly of the nucleosomes upstream of the RNA polymerase, influence the rate of fork progression on in vitro reconstituted chromatin templates 38 .
CCSER1 overexpression advances its replication timing and reduces its fragility in DT40 cells. We next enhanced the transcription of the 616-kb-long CCSER1 gene (Fig. 2) . CCSER1 (FAM190A) is poorly functionally characterized, although a role in cell division has been proposed in human cells 39 . CCSER1 orthologs are associated with human FRA4F and murine Fra6C1 CFSs
5
. CCSER1 is transcribed and is one of the most fragile regions of the DT40 genome after aphidicolin treatment 5, 12 . CCSER1 transcription was increased by placing both alleles of the gene under the control of the strong chicken β -actin promoter ( Supplementary Fig. 5 ). Unexpectedly, the ensuing ~20-fold increase in CCSER1 transcription ( Fig. 2a and Supplementary Fig. 5f ) was accompanied by a marked reduction of aphidicolin-induced CCSER1 instability (Fig. 2b, Supplementary  Fig. 2c , and Supplementary Table 1) . To understand why, we compared CCSER1 replication in WT and CCSER1 βa/βa cells (Fig. 2c -g and Supplementary Fig. 4b ). DNA-combing analyses with a specific set of FISH probes spanning CCSER1 ( Supplementary Fig. 3 ) showed a strong initiation zone overlapping the CCSER1 promoter region in WT cells, with some additional initiation events being apparently randomly distributed along the gene (Fig. 2c) . Notably, expression of CCSER1 from the β -actin promoter further favored segregation of initiation events upstream of the promoter at the expense of the rest of the gene (Fig. 2d) . In addition, termination events clustered in the third quarter of CCSER1 in CCSER1 βa/βa cells (Fig. 2d) , suggesting that the CCSER1 βa allele was mainly replicated by forks proceeding inward from the initiation zone located upstream of the β -actin promoter and from a second initiation region located 3′ of CCSER1. Together with DMD, our results support a model in which transcription dictates the replication initiation program of active large genes, as well as the ensuing termination profile. Fork velocity along the CCSER1 locus was also significantly increased following upregulation of CCSER1 transcription (Fig. 2g ), in agreement with our previous observations for DMD.
Notably, CCSER1 overexpression advanced the replication time of the 5′ part of the gene, which shifted from mid (mainly S3 fraction) to early S phase (mainly S1/S2 fractions) (Fig. 2f) . It also markedly advanced the replication time of the 3′ end of CCSER1 and its flanking region (Fig. 2f) . These data are consistent with those obtained by DNA combing (Fig. 2d) , reciprocally validating each other and further supporting that transcription, at least at a sufficient level, stimulates initiation both upstream and downstream of large genes. One possibility is that the coordinated timing shift observed in 5′ and 3′ of CCSER1 after overexpression might be mediated by long-range chromatin interactions. Advanced initiation at both ends of CCSER1 collectively led to a replication timing shift of the core of CCSER1 in CCSER1 βa/βa cells, mainly from late (S4 fraction) to mid-late (S3/S4 fractions) S phase (Fig. 2e,f) . These results suggest that the stability of CCSER1 βa alleles stems from the advancement of replication timing induced by the strong increase in transcription, which gives cells more time to complete replication before entering mitosis.
FHIT overexpression advances its replication timing and reduces its fragility in human HCT116 cells. We sought to extend our conclusions to FRA3B, the archetypal human CFS nested in the 1.5-Mb-long FHIT tumor suppressor gene 40 ( Fig. 3) . We used the CRISPR-Cas9 system to upregulate FHIT transcription in HCT116 epithelial cells ( Supplementary Fig. 6 ), where FRA3B is the most active CFS 5 . FHIT promoter region was substituted on both alleles with a cassette containing the strong human EF1α promoter ( Supplementary Fig. 6 ), which resulted in a ~20-fold increase in FHIT transcription (Fig. 3a) . This increase was accompanied by a strong reduction of FRA3B instability after aphidicolin treatment (Fig. 3b, Supplementary Fig. 2d , and Supplementary Table 1) , whereas, as expected, manipulation of FHIT transcription did not affect the frequency of breaks occurring on the long arm of chromosome 3, which contains FRA3O and FRA3P CFSs 5 ( Fig. 3b,  Supplementary Fig. 2d , and Supplementary Table 1 ). In addition, FHIT overexpression was associated with a shift to earlier replication of the core of FHIT from late (mainly S4 fraction in WT cells) to mid S phase (S2/S3 fractions in FHIT EF1α/EF1α cells) (Fig. 3c) . Thus, data from human cells are perfectly in agreement with those from DT40 cells, further substantiating our model in which high levels of transcription protect active large genes from fragility by advancing their replication timing. Notably, the 5′ and 3′ ends of FHIT replicated earlier than its central part in WT cells (Fig. 3c) . This profile was accentuated in FHIT EF1α/EF1α cells (Fig. 3c) , reminiscent of the replication timing profile of CCSER1 βa alleles (Fig. 2f) . These results confirm that high levels of transcription favor advanced initiation of replication both in 5′ and 3′ of active large genes, contributing to an earlier replication of the entire locus.
Transcription modulates replication timing in a level-dependent manner. To clarify the relationships between transcription level and replication timing of large genes, we compared a series of DT40 clones in which DMD was expressed at different levels. Notably, we used the β -actin promoter in addition to the Tet promoter to further increase DMD transcription (Fig. 4 and Supplementary Fig. 7 ).
To accurately determine the extent of the replication timing shift induced by either promoter, we generated heterozygous DMD +/βa and DMD +/Tet cells, which allowed us to quantify newly synthesized DNA produced at the promoter insertion site on either the WT or the modified allele in the same DNA preparation, enabling direct comparison between them. DMD transcription was approximately sevenfold higher in DMD +/βa than in DMD +/Tet cells grown with tetracycline (Fig. 4a ), yet, in line with previous results, DMD was twofold less fragile in DMD +/βa cells than in DMD +/Tet cells following aphidicolin exposure (Fig. 4b, Supplementary Fig. 2e , and Supplementary 
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observed at the insertion site of the Tet promoter in the absence of tetracycline ( Fig. 4c ). This change was slightly accentuated in the presence of tetracycline although the region remained predominantly late replicating ( Fig. 4c ), in agreement with the results obtained in homozygous cells (Fig. 1f) . Notably, we detected a strong shift to earlier replication at the β -actin promoter insertion site, from S4 to S2/S3 fractions ( Fig. 4d) . Thus, in line with CCSER1 and FHIT results, our data show that increasing transcription levels tend to advance replication timing (Fig. 4e) . Consistently, we found a significant correlation between the transcription level and the replication time at the promoter integration site under our different experimental conditions (Pearson's correlation coefficient ρ = − 0.9893, P = 0.0107; see Methods for details). In addition, above a certain threshold, transcription-associated advance in replication timing appears substantial enough to rescue the stability of active large genes ( Fig. 4b and Supplementary Table 1) .
Transcription-dependent shift in timing may be limited to genes over a certain size. Notably, it has been reported that the insertion in the genome of DT40 cells of the strong β -actin promoter upstream of a short gene has little impact on the replication timing of the targeted chromosomal region 30 .
To test whether a transcription-dependent shift in timing may be limited to genes over a certain size, we constructed heterozygous cells in which one CCSER1 allele was placed under the control of the β -actin promoter (CCSER1 +/ βa cells; Supplementary Fig. 5h ) and heterozygous cells in which transcription induced by the β -actin promoter was terminated by SV40 polyadenylation signals after the short puromycin resistance (puro) gene (CCSER1 +/βa-puro-polyA cells; Supplementary Fig. 8 ). We then directly compared the replication timing at the insertion site on either the wild-type allele or the allele containing the transgene in CCSER1
+/βa and CCSER1 +/βa-puro-polyA cell lines (Fig. 5a,b) . Insertion of the β -actin promoter alone induced a strong shift to earlier replication timing, from S2/S3 to S1/S2 fractions ( Fig. 5a ), in line with the results obtained in homozygous CCSER1
βa/βa cells (Fig. 2f ). In contrast, an extremely modest shift was detected when transcription was terminated ~1 kb downstream of the β -actin promoter (Fig. 5b) . Our data are therefore consistent with previous observations 30 and suggest that gene length influences the transcription-induced shift in replication timing, which may be limited to genes extending over a whole replication domain.
Finally, we generated cells with the 'β -actin-promoter-puro-SV40 polyadenylation signals' construct inserted downstream of CCSER1 exon 1 in one allele and a similar 'β -actin-promoterblasticidin-resistance (bsr) gene-SV40 polyadenylation signals' construct inserted at the same position in the other allele ( Supplementary Fig. 8 ). Notably, we observed that the ~95% decrease of CCSER1 mRNA level resulting from the early termination of CCSER1 transcription on both alleles by SV40 polyadenylation signals (Fig. 5c ) was associated with a near abolition of CCSER1 fragility in aphidicolin-treated cells (Fig. 5d, Supplementary Fig. 2c , and Supplementary Table 1), further substantiating a major role of transcription in fragility.
Discussion
We found that the degree of instability of large genes after replication stress correlates with their transcription level in an atypical way, with low transcription being more deleterious than high transcription levels. Although cause-and-effect relationships between transcriptional regulation and replication timing have fueled an intense debate 22 , our results strongly suggest that transcription regulates replication timing in a quantitative rather than qualitative manner. Notably, high levels of transcription are accompanied by an advancement of the replication time from late to mid S phase of all the three large genes that we studied and protect them from replication stress-induced breaks, which establishes a causal role for Articles NaTure STruCTural & MoleCular Biology late replication timing in CFS instability. The high transcriptionallevel-dependent shift in replication timing probably gives cells more time to complete replication before the onset of mitosis. Notably, it was observed in multiple cell types that active large genes are generally transcribed at low levels 10, 11 . Accordingly, they tend to replicate late during S phase 10 . Our results are therefore in line with recent genome-wide analyses concluding that CFSs specifically correspond to large, transcribed, late-replicating genes 10-12. They also explain why not all transcribed large genes are fragile 5, 41 . It is possible that, in addition to transcriptional activity, specific properties of the promoters used in this study contributed to the observed changes in replication timing. For instance, β -actin or EF1α promoters could create a favorable chromatin conformation associated with an earlier replication timing. However, we found that transcription termination by SV40 polyadenylation signals inserted ~1 kb downstream of the β -actin promoter prevents the strong shift to earlier replication timing induced by the promoter alone, indicating that actual transcription over a certain distance is essential for the replication timing shift. Moreover, we found a significant correlation between the transcription level and the replication time at the promoter insertion site in DMD under four different experimental conditions, namely the untranscribed WT allele, DMD Tet allele without tetracycline, DMD Tet allele with tetracycline, and DMD ßa allele, further suggesting that the observed shifts in timing are directly related to the level of transcriptional activity.
Our observations that transcription, at least at a sufficient level, favors initiation upstream and downstream of large genes is in line with recent studies proposing that transcription suppresses intragenic origin firing 33, 35 , possibly by interfering with the assembly of the prereplication complex 42, 43 or through the displacement or eviction of this complex by RNA polymerase II [44] [45] [46] [47] . This role of transcription in origin distribution prompts us to propose that initiation-poor regions and associated long-traveling forks observed in CFSs 4, 6, 7 actually originate from and reflect the active transcription of the cognate large genes. Whether CFS instability results from transcription-driven paucity in initiation events or transcriptiondependent formation of barriers impeding fork progression, or both phenomena, remains to be determined. It also remains to clarify the mechanisms responsible for the instability of the ~20% of CFSs apparently devoid of large transcription units βa-puro-polyA/βa-bsr-polyA cells (median and extreme values; n WT = 3 independent cell cultures, n CCSER1βa-puro-polyA/βa-bsr-polyA = 5). The experiment was performed independently three times. d, Aphidicolin-induced breaks at CCSER1 and PARK2 in WT and CCSER1 βa-puro-polyA/βa-bsr-polyA cells (median and extreme values; n values are independent cell cultures: for CCSER1, n WT = 4, n CCSER1βa-puro-polyA/βa-bsr-polyA = 6, for PARK2, n = 2; top, aggregate numbers). The experiment was performed independently four times for CCSER1 and twice for PARK2.
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CFSs have been detected in primates (human, chimpanzee, gorilla and macaque), mice, pigs, dogs, cats, and chickens 5, 12, 25 . Almost all CFSs conserved in humans, mice, and chicken described so far are nested in orthologous large genes 5, 12, 25 . Moreover, large fragile genes in Gallus gallus have resisted the global tendency of genome size reduction observed in birds 12 . The conservation of large genes through evolution despite their fragility therefore suggests that they have a beneficial function 12, 48, 49 . However, many large genes have been implicated in neurodevelopmental and neuropsychiatric disorders 11, 50 ; mutations in human DMD cause Duchenne muscular dystrophy, Becker muscular dystrophy, or cardiomyopathy 29 . The inherent susceptibility of genes of proven physiological importance to genomic instability seems difficult to understand from an evolutionary point of view, unless it constitutes an important source of diversity. Nevertheless, it should be noted that large genes are usually expressed in differentiated cells, typically neurons 51 , in which they are not susceptible to instability, as these cells do not replicate their genome. For instance, DMD should remain stable, whatever its transcription level, in the fully differentiated skeletal or cardiac muscle cells where it is predominantly expressed 29 . Transcription of large genes should only pose a threat to genome stability in proliferating cells, essentially germ cells, stem cells, and cancer cells. Interestingly, it has recently been proposed that the recurrent genomic alterations detected at late-replicating active large neural genes in neuronal stem/progenitor cells may contribute to produce neuronal diversity and participate in normal neurological development, although they could predispose to mental disorders 11 . Regarding cancer cells, we propose that the large genes expressed in the cell type from which the cancer derives will probably exhibit genomic instability if they remain expressed in the cancer cells at a level compatible with late replication. Oncogeneinduced changes affecting large gene transcription also contribute to the fragility landscape in tumors 41 . One can speculate that only those resulting in a transcription level associated with a late replication timing are deleterious.
In conclusion, although transcription is currently considered to be a primary threat to genome stability, our study reveals complex relationships between transcription, replication, and chromosome fragility. The multifaceted impact of transcription on replication calls for a careful assessment of the mutational consequences of transcriptional changes, especially in cancer cells where upregulation of transcription is suspected to be a major contributor of oncogene-induced replication stress 52 .
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Methods Cell lines and cell culture. DT40 cells were grown in RPMI 1640 GlutaMAX medium (Gibco) with 10% fetal bovine serum (Biowest), 2% chicken serum (Gibco) and 0.1 mM β -mercaptoethanol (Millipore). A tetracycline-free fetal bovine serum (Biowest) was used when appropriate. HCT116 human colon carcinoma cells were cultured in McCoy's 5A medium (Gibco) with 10% fetal calf serum and 20 mM l-glutamine (Gibco) except for replication timing experiments for which they were cultured in DMEM (4.5 g l −1 d-glucose, l-glutamine) (Gibco) with 10% fetal calf serum and 1 mM sodium pyruvate. All media were supplemented with 100 U ml −1 penicillin and 100 µ g ml −1 streptomycin (Gibco). Cells were grown at 37 °C, 20% O 2 , 5% CO 2 .
The DT40 cell line was provided by M. N. Prioleau. HCT116 cells were obtained from ATCC. DT40 cell line was authenticated by DAPI-stained metaphase chromosome spreads which exhibited the typical DT40 karyotype, notably the presence of three macrochromosomes 2. The HCT116 cell line was authenticated by conventional cytogenetics which identified the rearranged chromosome 10 and the translocation between chromosomes 8 and 16 typical of the HCT116 karyotype. DT40 and HCT116 cells and derivative clones were routinely confirmed to be negative for mycoplasma contamination.
Tet-On inducible system. A Tet-On system based on the T-REx System (Invitrogen) was used to induce the transcription of DMD on addition of the tetracycline antibiotic. Briefly, the tetracycline-inducible promoter (Tet promoter) used consists of a cytomegalovirus promoter into which two copies of the Tetoperator 2 (TetO) sequence have been inserted in tandem. In the absence of tetracycline, transcription is repressed by the high affinity binding of the Tet repressor (TetR) to the TetO. Addition of tetracycline results in the release of TetO by the TetR and derepression of the promoter. The Tet promoter was amplified from a pcDNA4/TO vector (Invitrogen). The TetR was expressed from a pcDNA6/ TR vector (Invitrogen).
Constructs.
Targeting constructs for homologous recombination in DT40 cells were created from loxP vectors 53 using standard molecular biology and cloning protocols. Approximately 2-kb-long 5′ and 3′ homology regions were amplified from DT40 genomic DNA with primers listed in Supplementary Table 2. The chicken β -actin promoter was synthesized by GeneScript. All constructs were checked for mutations by sequencing. Guide RNAs targeting FHIT promoter (gRNA1: GCCAAATGCCATGTGGGTGC; gRNA2: TCAATTTAGATTTCGGCTTC) were designed using the gRNA design tool from DNA2.0. The gRNA/Cas9 plasmid containing sequences for the two gRNAs and wtCas9 was synthesized by DNA2.0. Approximately 1-kb-long 5′ and 3′ homology regions flanking the CRISPR-Cas9 cutting sites were amplified from RP11-137N22 bacterial artificial chromosome with primers listed in Supplementary Table 2 and cloned into the HR710PA-1 plasmid (System Biosciences) on each side of the EF1α promoter-hygromycin selection cassette. Detailed cloning procedures are available on request.
Transfection and genotyping.
Exponentially growing DT40 cells (10 7 ) were electroporated with 35 μ g of the linearized construct using a Bio-Rad electroporator set at 25 μ F and 550 V for targeted integrations, 960 μ F and 250 V for the random insertion of the pcDNA6/TR vector. Recombinant clones were selected with either 21.75 μ g ml −1 blasticidin, 0.5 μ g ml −1 puromycin or 450 μ g ml −1 zeocin, identified by PCR using LA Taq DNA Polymerase (TaKaRa) and confirmed by Southern blot. At least two positive clones were randomly selected and amplified for further studies. Primers used for genotyping are listed in Supplementary Table 2 . Probes used for Southern blot were amplified from the targeting constructs using primers listed in Supplementary Table 2 .
For transient transfection, 3 × 10 6 exponentially growing DT40 cells were transfected with 5 μ g of a reporter plasmid expressing the luciferase gene under the control of the Tet promoter using the Amaxa Nucleofector system (T solution, program B-023).
HCT116 cells were cotransfected with 1 µ g gRNA-Cas9 plasmid and 1 µ g HR710PA-1-FHIT plasmid using FuGENE HD Transfection Reagent (Promega) according to the manufacturer's instructions. Recombinant cells were selected with 200 µ g ml −1 hygromycin B (Invitrogen) 48 h post-transfection. Ganciclovir (2 µ M) was added to the culture medium 7 d post-transfection to counter-select cells containing randomly integrated HR710PA-1-FHIT plasmid. After a further 12 d, single clones were selected and amplified. Positive clones were identified by PCR and confirmed by sequencing.
Luciferase reporter assay. DT40 clonal cell lines expressing the Tet repressor were tested for their ability to induce transcription of the luciferase reporter gene on addition of tetracycline, which was quantified by the light emitted during an enzymatic reaction of bioluminescence using the Dual-Glo Luciferase Assay System (Promega) according to the manufacturer's instructions. Luminescence was measured using a luminometer 24 h after addition of 1 μ g ml −1 tetracycline (Sigma) to the culture medium.
Tetracycline-induced transcriptional activation of DMD. Transcriptional activation of DMD was achieved with a 24 h treatment of DMD Tet/Tet and DMD +/Tet cells with 1 μ g ml −1 tetracycline. A low transcriptional background from the Tet promoter is detected even without tetracycline (Figs. 1a and 4a) , as previously reported 54 .
Floxed cassette excision. The DT40 cell line used in this study contains a stably integrated MerCreMer plasmid 53 . The protein is inactive in the absence of 4-hydroxytamoxifen due to the hormone binding domains of the mutated estrogen receptor fused either side of the Cre recombinase. For excision of floxed cassettes, cells were cultured for 24 h with 0.5 μ M 4-hydroxytamoxifen then distributed into 96-well flat-bottom microtiter plates at a concentration of 1, 3, and 30 viable cells per well. Isolated colonies were tested for cassette excision by loss of antibiotic resistance and PCR. mRNA quantification. DT40 cells were collected during their exponential growth phase. Total RNA was extracted using miRNeasy Mini Kit (Qiagen) according to the manufacturer's instructions and treated with DNase (Roche). Total RNA (1 μ g) was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad). Real-time quantitative PCR reactions (qPCR) were set up using GoTaq qPCR Master Mix (Promega) and run on a LightCycler 480 II (Roche). Each reaction was performed in triplicate. DNA contamination was quantified in reverse transcriptase-free reactions. Primer sequences are listed in Supplementary Table 2 . Each primer pair spanned one intron to avoid unwanted amplification of genomic DNA. The efficiency of each primer pair was tested by performing qPCR with the same protocol on increasing dilutions of cDNA (from 1/10 to 1/10,000 dilutions) and calculated using the coefficient of amplification. The efficiency of each pair being similar, it is possible to directly compare the amount of each amplification product. mRNA levels were quantified relative to β -actin (ACTB) mRNA. For DMD Tet/Tet , DMD
+/Tet
, and DMD +/βa cells, mRNA levels were quantified before the excision of the floxed selection cassettes. For each construct, mRNA quantification experiments were performed using at least two different clonal cell lines.
Quantification of 5-ethynyl uridine incorporation into nascent RNAs.
Exponentially growing DT40 or HCT116 cells were treated for 1 h with 0.5 or 0.2 mM 5-ethynyl uridine, respectively. 5-ethynyl uridine-labeled RNA was captured using the Click-iT Nascent RNA Capture Kit (Invitrogen) according to the manufacturer's instructions. Briefly, 1 μ g of total RNA was biotinylated thanks to the click reaction between 5-ethynyl uridine and azide-modified biotin, then purified using streptavidin magnetic beads. Nascent RNAs were reverse transcribed on the beads using Superscript Kit (Invitrogen). Real-time qPCR were performed using intra-intronic primers listed in Supplementary Table 2. All primers had similar efficiencies. RNA levels were calculated relative to β -actin (DT40 cells) or cyclophilin B (HCT116 cells) transcript quantities. Nascent RNA quantification experiments were performed using at least two different clonal cell lines for each DT40 construct; they were performed twice for HCT116 cells using one FHIT EF1α/EF1α clonal cell line.
FISH on metaphase chromosomes. DT40 and HCT116 cells were grown for 16 h with 0.6 and 0.15 μ M aphidicolin, respectively. Metaphase spreads were prepared according to standard cytogenetic procedures after a 3 h treatment with 0.1 μ g ml
colcemid for DT40 cells and a 2 h treatment with 100 nM nocodazol for HCT116 cells. For untreated DT40 cells, metaphase spreads were prepared after a 1.5 h treatment with 0.1 μ g ml −1 colcemid. For DT40 FISH analyses, probes correspond to adjacent 5-kb-long PCR products spread over ~50 kb delimiting DMD, CCSER1 or PARK2 genes and amplified from DT40 genomic DNA with primers listed in Supplementary Probes were labeled either with biotin using the BioPrime DNA labeling system (Invitrogen) or with digoxigenin using the DIG DNA labeling mix (Roche) and subsequently purified on Illustra ProbeQuant G-50 Micro Columns (GE Healthcare). FISH was performed essentially as described 55 without the proteinase K step and using 75 ng of each probe. Chicken Hybloc DNA (Amplitech) was used as a repetitive sequence competitor DNA. Immunodetection was performed by successive incubations in the following reagents: (1) for biotinylated probes, (i) Alexa Fluor 555-conjugated streptavidin (Invitrogen), (ii) biotin-conjugated rabbit anti-streptavidin (Rockland Immunochemicals), (iii) Alexa Fluor 555-conjugated streptavidin (Invitrogen); (2) for digoxigenin-labeled probes, (i) FITC-conjugated mouse anti-digoxin (Jackson ImmunoResearch), (ii) Alexa Fluor 488-conjugated goat anti-mouse (Invitrogen). Chromosomes were counterstained with 4′ ,6-diamidino-2-phenylindole (DAPI) (Vectashield mounting medium for fluorescence with DAPI; Vector Laboratories) and metaphases were observed by fluorescence microscopy. Aphidicolin-induced breaks at the 679.5-kb-long PARK2 gene were used as a control to demonstrate that modulation of DMD or CCSER1 transcription specifically impacts the fragility of those genes and that the limited perturbations of cell physiology observed in CCSER1 βa/βa and CCSER1 βa-puro-polyA/βa-bsr-polyA cells (Supplementary Figs. 5d ,e and 8d,e) do not perturb break induction by aphidicolin. For each construct, FISH experiments were performed using at least two different clonal cell lines.
FISH analysis of FRA3B fragility in HCT116 cells was performed using 50 ng of biotinylated RP11-641C17 (AC104164), RP11-32J15 (AC104161) and RP11-147N17 (AC104300) bacterial artificial chromosomes. Immunodetection was performed by successive incubations in Alexa Fluor 488-conjugated streptavidin (Invitrogen) and biotin-conjugated rabbit anti-streptavidin (Rockland Immunochemicals). Cot-1 DNA (Invitrogen) (15 µ g) was used as a repetitive sequence competitor DNA. Chromosomes 3 were unambigously identified using a specific centromeric probe. Aphidicolin-induced breaks on the long arm of chromosome 3 (Chr 3q) were used as a control to demonstrate that FHIT overexpression specifically impacts FRA3B fragility. FISH experiments were performed using one FHIT EF1α/EF1α clonal cell line.
Bivariate fluorescence-activated cell sorting (FACS) analysis. Cell cycle analyses were performed as follows. Exponentially growing DT40 cells were pulse-labeled for 15 min with 30 μ M bromodeoxyuridine (BrdU) and fixed in ethanol. After partial denaturation of DNA following HCl/pepsin treatment, immunodetection was performed by incubations with rat anti-BrdU (Bio-Rad, formerly AbD Serotec) then Alexa Fluor 488-conjugated chicken anti-rat (Invitrogen). DNA was counterstained with propidium iodide in the presence of 25 μ g ml −1 RNase. Samples were analyzed using a BD Biosciences LSRII flow cytometer with BD FACSDiva software. Data were processed using FlowJo v8.7.3. Gating strategy is illustrated in Supplementary Figure 8g .
Cell growth and doubling time. The cumulative growth curves of the DT40 cell lines used in this study were determined after normalization for dilution at each subculture. Doubling times were estimated on the basis of the growth curves. Replication timing analyses. Timing analyses in DT40 cells were made as previously described 30 . Briefly, exponentially growing DT40 cells were pulselabeled for 1 h with 50 μ M BrdU, fixed in ethanol and stored at − 20 °C overnight. Fixed cells were resuspended in 1× PBS with 50 μ g ml −1 propidium iodide and 0.5 or 1 mg ml −1 RNase, and incubated for 30 min at room temperature. Cells were sorted by flow cytometry on the basis of their nuclear content using a BD Biosciences INFLUX cell sorter with the BD FACS Sortware software (v1.0.0.650). The S phase was divided into four fractions from early to late S phase, named S1 to S4. Cells (50,000) were sorted in each fraction. DNA was extracted by phenol/ chloroform, sonicated to obtain fragments between 500 and 1,000 bp in size, and BrdU-labeled DNA was immunoprecipitated using mouse anti-BrdU (BD Biosciences). Real-time qPCR was performed using the Roche LightCycler 2.0 detection system with the Absolute QPCR-SYBR Green mix (ThermoFisher Scientific). For each reaction, amplification of the purified BrdU-labeled DNA was performed in duplicate. As mitochondrial DNA replicates throughout the cell cycle and should be equally represented in every fraction, the amount of immunoprecipitated DNA in each S-phase fraction was normalized by the abundance of mitochondrial DNA measured using a specific primer pair (MIT). Quality control experiments were performed to confirm enrichment of known early-, mid-and late-replicated loci in the expected fractions (Supplementary Table 3 ). In heterozygous cells, primer pairs overlapping the site of insertion and next to the site of insertion of the Tet or β -actin promoters were used to detect the timing of the wild-type allele (without primers) and both alleles (both primers), respectively. A primer pair specific to the transgene ('with' primers) was used to analyze the timing of the modified allele. For each construct, replication timing analyses were performed on two different clonal cell lines.
For replication timing analyses of FHIT, exponentially growing HCT116 cells were pulse-labeled for 1 h with 50 μ M BrdU, fixed in ethanol and incubated overnight at − 20 °C in the presence of 15 μ g ml −1 Hoescht 33342 (ThermoFisher Scientific). Fixed cells were resuspended in 1× PBS and cells were sorted by flow cytometry on the basis of their nuclear content using a BD Biosciences INFLUX cell sorter. The S phase was divided into four fractions, from early to late S phase (S1 to S4). To check the quality of sorted HCT116 fractions, the post-sort cells, already stained with Hoescht 33342, were directly re-analyzed by flow cytometry. DNA was isolated using Maxwell RSC Blood DNA kit (Promega) according to the manufacturer's instructions, and sonicated. For each fraction, immunoprecipitation of BrdU-labeled DNA was performed on 5 μ g of DNA using mouse anti-BrdU (BD Biosciences). Immunoprecipitated DNA was further extracted by phenol/ chloroform, and real-time qPCR was performed using QuantiNova SYBR Green PCR kit (Qiagen) on a 7300 Real-Time PCR System (Applied Biosystems). Replication timing analyses were performed twice using one FHIT EF1α/EF1α clonal cell line.
All primer pairs used for replication timing analyses are listed in Supplementary Table 2.
Correlation between the transcription level and the replication time at the Tet or β-actin promoter insertion site in DMD. For each condition, namely 'without' , 'with Tet − tetracycline' , 'with Tet + tetracycline' , and 'with β -actin' , a score reflecting the average timing of replication during S phase was calculated on the basis of the the percentage of BrdU-labeled DNA in each fraction relative to total S phase presented in Fig. 4e , with 25, 50, 75 and 100 corresponding to S1, S2, S3, and S4, respectively. For instance, the score for the 'without' condition is (25 × 4.59%) + (50 × 5.39%) + (75 × 15.37%) + (100 × 74.65%) = 90.0, reflecting a predominant replication timing in the S4 fraction. The replication timing score for the 'with Tet − tetracycline' , 'with Tet + tetracycline' and 'with β -actin' conditions are 86.8, 83.8, and 56.4, respectively. Transcription values are those presented in Figure 4a , corresponding to the relative DMD nascent RNA level measured downstream of the promoter insertion site using the i1b primer pair. Pearson's correlation test between transcription level and replication timing was performed using an R script (two-sided; assuming bivariate normal distribution; two degrees of freedom). Pearson's correlation coefficient ρ = − 0.9893 (95% confidence interval (− 0.9998; − 0.5729)), P = 0.0107. DNA combing. Neo-synthesized DNA was labeled as described 56 with the following changes: exponentially growing DT40 cells were pulse-labeled for 20 min with 20 μ M iododeoxyuridine (IdU) followed by a 20-min pulse with 100 μ M chlorodeoxyuridine (CldU), then by a 5 min chase with 1 mM thymidine. Genomic DNA was extracted and combing was performed on silanized coverslips prepared by plasma cleaning and liquid-phase silanization as described 57,58 using a Genomic Vision apparatus.
FISH on combed DNA and immunofluorescence detection of neo-synthesized DNA. Morse codes were designed as described 59 to specifically identify DNA molecules spanning the DMD or CCSER1 loci. Morse-code probes correspond to a collection of ~5-kb-long PCR products spread all over the locus of interest, separated by precise distances and divided into voluntarily different and asymmetrical patterns to correctly orient the DNA fiber. Morse codes for DMD and CCSER1 detection are made of 32 probes and 27 probes, respectively. PCR products were prepared and labeled with biotin as described above for FISH on metaphases. Primer pairs used are listed in Supplementary Table 2 . Hybridization of the probes was carried out as described previously Image acquisition. Images were acquired on a motorized XY stage of an Axio Imager Z2 (Carl Zeiss) or a DM6000 B (Leica) epifluorescence microscope connected to a CoolSNAP HQ2 charge-coupled device camera (Roper Scientific) and run by Metamorph software (Molecular Devices). A × 100 objective was used for imaging methaphase chromosomes and a × 63 objective was used for imaging combed DNA fibers. For images of the DMD and CCSER1 loci, two overlays of images were set up for each microscope field. The first one combined the IdU/ CldU and FISH signals to identify the fibers of interest, replicating or not. The second overlay combined the IdU, FISH and DNA signals to determine the length of the DNA fiber bearing the Morse code. DNA counterstaining was systematically used to ensure that (1) several fibers are not overlapping, (2) replication signals belong to the same fiber, and (3) replication signals are intact.
Signal treatment. Measurement of DNA fiber and replication tract length was performed on imaged DNA molecules using Adobe Photoshop CS5.1. DNA fibers bearing Morse-code signals were modeled and aligned on a schematic representation of the DMD or CCSER1 loci using Adobe Illustrator CS5.1. Graphical representations of DMD and CCSER1 were drawn on the basis of the locus length, the theoretical ~2 kb μ m −1 stretching factor of the combing apparatus indicated by the manufacturer, and the resolution of the camera at a magnification of × 63 (0.1024 μ m per pixel). For instance, the 996,168-bp DMD gene corresponded to 996.168/2/0.1024 = 4,864.1 pixels. Morse-code probes were used to calculate the actual stretching factor of each DNA molecule by comparing the length of the fiber imaged with the microscope with the theoretical length defined according to the position of the probes. Overall, we found a mean stretching factor of 1.93 kb μ m . Therefore, to prevent that variation in the stretching of the DNA molecules during the combing step introduce a bias in tract measurement, the lengths of IdU and CldU tracts were normalized by the stretching factor of the DNA fiber on which they were located. For bulk genome analyses, the lengths of IdU and CldU tracts were normalized by the mean stretching factor calculated when analyzing DMD or CCSER1 loci using the exact same sample and coverslip batch. Replication fork speed was then estimated on individual forks as (1) the ratio (l Idu + l CldU )/(t IdU + t CldU ) for forks displaying an intact IdU tract flanked on one side by an intact CldU tract, (2) the ratio l Idu /t IdU for forks with an intact IdU signal flanked on one side by a broken CldU signal and (3) the ratio l Cldu /t CldU for forks with an intact CldU signal flanked on one side by a broken IdU signal, with l IdU and t IdU being the measured length (in kb) and labeling time (in min) for IdU incorporation, respectively, and l CldU and t CldU the corresponding parameters for CldU incorporation. For all experiments, t IdU = t CldU = 20 min. Replication signal integrity was ascertained by DNA counterstaining. For fork progression analyses in DMD and CCSER1, only forks overlapping at least partially these loci were taken into account. Coordinates and length of DNA molecules and replication signals were compiled using Microsoft Excel for Mac 2011. DNA combing results for WT cells (bulk genome and CCSER1 and DMD loci) compile DNA fibers from two distinct biological samples, DNA combing results for DMD Tet/Tet cells with tetracycline compile DNA fibers from two clonal cell lines and DNA combing results for CCSER1 βa/βa cells originate from one biological sample.
Statistics and reproducibility. Statistical comparisons of fork speed distributions
were assessed with the non-parametric Mann-Whitney-Wilcoxon test (two-tailed) using GraphPad Prism 6 (GraphPad Software). No assumptions or corrections were made. Statistical significance was set to P ≤ 0.05.
The number of times experiments presented in Fig. 1 were performed as follows. For all experiments, apart from the normalization to β -actin or cyclophilin B in mRNA levels or 5-ethynyl uridine incorporation into nascent RNAs quantification experiments, results are presented without any experimental readjustment. Note that, for DT40 cells, several mutant clonal cell lines were typically tested alongside WT cells, explaining why n values are often higher than the number of independent experiments.
Coverage profile. Graphical representations of 'total DNA' and 'DNA with replication' coverages of DMD and CCSER1 were made with R 60 using custom scripts adapted from ref. 61 .
Genomic coordinates and genome annotations.
Coordinates are given according to the ICGSC/galGal4 chicken genome or the GRCh37/hg19 human genome assemblies. DMD is the largest annotated gene of the chicken genome both in the latest RefSeq and Ensembl gene annotations available when this work was performed.
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